De Bolle, Naesens LL, De Clercq E (2005) Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18(1):217–245
Article PubMed PubMed Central Google Scholar
Clark DA (2016) Clinical and laboratory features of human herpesvirus 6 chromosomal integration. Clin Microbiol Infect 22(4):333–339
Article CAS PubMed Google Scholar
Kampouri E et al (2024) Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications. Curr Opin Infect Dis 37(4):245–253
Article CAS PubMed Google Scholar
Wang H et al (2024) Clinical and histopathologic characteristics of acute severe Hepatitis Associated with Human Herpesvirus 6 infection. Am J Surg Pathol 48(9): 1117-1130
Toomey D et al (2023) Viral encephalitis after hematopoietic cell transplantation: a systematic review. Transpl Cell Ther, 29(10): 636.e1-636.e9
Jacobson CA et al (2024) Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. Transplant Cell Ther, 30(1): p. 77.e1-77.e15
Yuan S, Chen Y, Liu H (2024) Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma. Ther Adv Hematol 15:20406207241237594
Article PubMed PubMed Central Google Scholar
Spanjaart AM et al (2022) Confused about confusion. N Engl J Med 386(1):80–87
Mardente S et al (2023) HHV-6A infection of papillary thyroid Cancer cells induces several effects related to Cancer Progression. Viruses 15(10): 2122
Grut V et al (2024) Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain 147(1):177–185
Badrinath A, Bhatta S, Kloc A (2022) Persistent viral infections and their role in heart disease. Front Microbiol 13:1030440
Article PubMed PubMed Central Google Scholar
Ogata M et al (2006) Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 193(1):68–79
Article CAS PubMed Google Scholar
Batlevi CL et al (2016) Novel immunotherapies in lymphoid malignancies. Nat Rev Clin Oncol 13(1):25–40
Article CAS PubMed Google Scholar
Lareau CA et al (2023) Latent human herpesvirus 6 is reactivated in CAR T cells. Nature 623(7987):608–615
Article CAS PubMed PubMed Central Google Scholar
Yamshon S et al (2024) Safety and toxicity profiles of CAR T cell therapy in Non-hodgkin Lymphoma: a systematic review and Meta-analysis. Clin Lymphoma Myeloma Leuk, 24(6): e235-e256.e2.
Pinto SN, Krenciute G (2024) The mechanisms of altered blood-brain barrier permeability in CD19 CAR T-Cell recipients. Int J Mol Sci, 25(1): 644
Sterner RC, Sterner RM (2022) Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy. Front Immunol 13:879608
Article CAS PubMed PubMed Central Google Scholar
Neelapu SS (2019) Managing the toxicities of CAR T-cell therapy. Hematol Oncol 37(Suppl 1):48–52
Article CAS PubMed Google Scholar
Lakomy T et al (2023) Early Use of corticosteroids following CAR T-Cell therapy correlates with reduced risk of high-Grade CRS without negative impact on neurotoxicity or treatment outcome. Biomolecules, 13(2): 382
Kampouri E, Handley G, Hill JA (2024) Human herpes Virus-6 (HHV-6) reactivation after hematopoietic cell transplant and Chimeric Antigen Receptor (CAR)- T cell therapy: a shifting Landscape. Viruses, 16(4): 498
Kampouri E et al (2024) Human Herpesvirus-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients. Blood 144(5): 490-495
Yassin A et al (2020) Clinical, radiological, and electroencephalographic features of HHV-6 encephalitis following hematopoietic stem cell transplantation. Ann Med Surg (Lond) 60:81–86
Singh N, Paterson DL (2000) Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 69(12):2474–2479
Article CAS PubMed Google Scholar
Bhanushali MJ et al (2013) Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology 80(16):1494–1500
Article PubMed PubMed Central Google Scholar
Lee DW et al (2019) ASTCT Consensus Grading for Cytokine Release Syndrome and neurologic toxicity Associated with Immune Effector cells. Biol Blood Marrow Transpl 25(4):625–638
Rubin DB et al (2019) Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain 142(5):1334–1348
Beuchat I et al (2022) EEG findings in CAR T-cell-associated neurotoxicity: clinical and radiological correlations. Neuro Oncol 24(2):313–325
Li A et al (2020) Direct economic burden of patients with autoimmune encephalitis in western China. Neurol Neuroimmunol Neuroinflamm, 7(6): e891
Lapidus AH et al (2022) Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Leuk Lymphoma 63(10):2364–2374
留言 (0)